Drug Pipeline

Drug Pipeline Market Research Reports

1 . Drug Pipeline Market Research Reports Analysis and Trends

Discovering and bringing new drugs to mainstream commercial market typically takes an average of 10-15 years of research and clinical development efforts. Drug developers need to make sure safe and effective drug available for patient in quick time. The first step is to target the protein available in the patient’s body that is associated with microorganism causing a disease, through tracking of cellular network of proteins an appropriate target for a drug is selected. Through a series of trials, right drug candidate got chosen.
 
According to “NOVARTIS”, bringing a new drug in market takes 14 years of research and cost around USD 2 billion, 10K+ clinical trials out of these, one leads to successful drug development.
Titlesort descending Published Pages Price
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2019 Dec 27 2019 101 USD 2,000.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2020 Oct 30 2020 127 USD 2,000.00
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Jul 29 2022 105 USD 2,000.00
Acid Sphingomyelinase Deficiency Type C (Genitourinary Disorders) - Drugs In Development, 2021 Jul 30 2021 139 USD 2,000.00
Acinetobacter Infections (Infectious Disease) - Drugs In Development, 2021 Jul 30 2021 229 USD 2,000.00
Acinetobacter Infections - Pipeline Review, H1 2018 Apr 10 2018 154 USD 2,000.00
Acinetobacter Infections - Pipeline Review, H1 2020 Apr 30 2020 192 USD 2,000.00
Acinetobacter Infections - Pipeline Review, H2 2018 Oct 30 2018 169 USD 2,000.00
Acinetobacter Infections - Pipeline Review, H2 2019 Dec 27 2019 181 USD 2,000.00
Acinetobacter Infections - Pipeline Review, H2 2020 Oct 30 2020 204 USD 2,000.00
Acinetobacter Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Jul 29 2022 173 USD 2,000.00
Acne Vulgaris (Dermatology) - Drugs In Development, 2021 Jul 30 2021 252 USD 2,000.00
Acne Vulgaris - Pipeline Review, H1 2018 Apr 30 2018 182 USD 2,000.00
Acne Vulgaris - Pipeline Review, H1 2020 Apr 30 2020 224 USD 2,000.00
Acne Vulgaris - Pipeline Review, H2 2018 Oct 16 2018 186 USD 2,000.00
Acne Vulgaris - Pipeline Review, H2 2019 Dec 27 2019 228 USD 2,000.00
Acne Vulgaris - Pipeline Review, H2 2020 Oct 30 2020 217 USD 2,000.00
Acne Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Jul 29 2022 164 USD 2,000.00
Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021 Apr 30 2021 50 USD 2,000.00
Acquired (Autoimmune) Hemolytic Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 210 USD 2,500.00
Acral Lentiginous Melanoma (Oncology) - Drugs in Development, 2021 Apr 30 2021 30 USD 2,000.00
Acral Lentiginous Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 35 USD 2,000.00
Acromegaly (Hormonal Disorders) - Drugs In Development, 2021 Jul 30 2021 113 USD 2,000.00
Acromegaly - Pipeline Review, H1 2018 Mar 27 2018 80 USD 2,000.00
Acromegaly - Pipeline Review, H1 2020 Mar 31 2020 103 USD 2,000.00
Acromegaly - Pipeline Review, H2 2018 Sep 26 2018 89 USD 2,000.00
Acromegaly - Pipeline Review, H2 2019 Nov 18 2019 102 USD 2,000.00
Acromegaly - Pipeline Review, H2 2020 Sep 30 2020 96 USD 2,000.00
Acromegaly Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Jun 30 2022 78 USD 2,000.00
Actinic (Solar) Keratosis (Dermatology) - Drugs In Development, 2021 Jul 30 2021 77 USD 2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H1 2018 Mar 27 2018 61 USD 2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H1 2020 Mar 31 2020 66 USD 2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H2 2018 Sep 26 2018 63 USD 2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H2 2019 Nov 18 2019 68 USD 2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H2 2020 Sep 30 2020 69 USD 2,000.00
Actinic (Solar) Keratosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 68 USD 2,000.00
Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) - Pipeline Review, H1 2018 Jun 12 2018 45 USD 3,500.00
Activin Receptor Type 1 - Pipeline Review, H1 2020 Feb 28 2020 70 USD 3,500.00
Activin Receptor Type 1 - Pipeline Review, H2 2019 Dec 27 2019 75 USD 3,500.00
Acute Bronchitis (Respiratory) - Drugs in Development, 2021 Apr 30 2021 30 USD 2,000.00
Acute Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 35 USD 2,000.00
Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 Apr 30 2021 50 USD 2,000.00
Acute Coronary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 54 USD 2,000.00
Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021 Apr 30 2021 50 USD 2,000.00
Acute Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 51 USD 2,000.00
Acute Inflammation (Immunology) - Drugs in Development, 2021 Apr 30 2021 45 USD 2,000.00
Acute Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 45 USD 2,000.00
Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 Apr 30 2021 125 USD 2,000.00
Acute Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 114 USD 2,000.00
Acute Liver Failure (Gastrointestinal) - Drugs in Development, 2021 Apr 30 2021 45 USD 2,000.00

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected